Walleye Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Walleye Capital's ELV Position: Q2 2026 in Review
Walleye Capital reduced its Elevance Health (ELV) stake by 54% in Q2 2026, selling an estimated $610K and leaving 1,380 shares worth $534K. The position accounts for ﹤0.01% of the portfolio, ranked #2668.
Walleye Capital first reported a position in ELV in Q3 2018 and has held it in 18 quarters since. The position peaked at $38.3M in Q4 2025. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Walleye Capital held 1,380 shares of Elevance Health worth $534K as of Q2 2026.
- Walleye Capital sold 1,644 Elevance Health shares in Q2 2026, an estimated $610K.
- Elevance Health made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2668 holding.
- Walleye Capital first reported a position in Elevance Health in Q3 2018 and has held it in 18 quarters since.
- Walleye Capital's Elevance Health position peaked at $38.3M in Q4 2025.
- 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.